Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients

Jodie A. Barkin, Amy Westermann, William Hoos, Cassadie Moravek, Lynn Matrisian, Hongwei Wang, Lynn Shemanski, Jamie S Barkin, Lola Rahib

Research output: Contribution to journalArticle

Abstract

Pancreatic cancer (PC) and its treatments can result in pancreatic exocrine insufficiency that requires pancreatic enzyme replacement therapy (PERT). Appropriate PERT usage is during meals and snacks. The aim was to determine the frequency of appropriate use of PERT and its impact on symptom alleviation in PC through a patient-reported outcomes online platform. Methods Users in the Pancreatic Cancer Action Network's Patient Registry were prompted to answer a standalone questionnaire about their experience with PERT. Results Two hundred sixty-two users completed the PERT questionnaire (January 2016-January 2018). Patients who reported taking PERT with meals had higher alleviation of symptoms compared with those taking PERT prior to or after meals. Specifically, "feeling of indigestion," "light-colored or orange stools," and "visible food particles in stool" were significantly decreased. Patients taking PERT with meals reported weight gain and less weight loss. Conclusions Of the 89% of PC patients prescribed PERT, 65% were prescribed PERT appropriately with all meals and snacks. Overall compliance with PERT administration guidelines was low (50% [105/208]). Improvement in symptoms significantly correlated with appropriate use of PERT. Increase in PC patient and provider education about appropriate PERT usage and administration is warranted.

Original languageEnglish (US)
Pages (from-to)780-786
Number of pages7
JournalPancreas
Volume48
Issue number6
DOIs
StatePublished - Jul 1 2019

Fingerprint

Enzyme Replacement Therapy
Pancreatic Neoplasms
Meals
Snacks
Exocrine Pancreatic Insufficiency
Dyspepsia
Patient Education
Weight Gain
Registries

Keywords

  • pancreatic cancer
  • pancreatic enzyme replacement therapy
  • pancreatic enzymes
  • pancreatic exocrine insufficiency
  • symptom alleviation
  • weight loss

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Barkin, J. A., Westermann, A., Hoos, W., Moravek, C., Matrisian, L., Wang, H., ... Rahib, L. (2019). Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients. Pancreas, 48(6), 780-786. https://doi.org/10.1097/MPA.0000000000001330

Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients. / Barkin, Jodie A.; Westermann, Amy; Hoos, William; Moravek, Cassadie; Matrisian, Lynn; Wang, Hongwei; Shemanski, Lynn; Barkin, Jamie S; Rahib, Lola.

In: Pancreas, Vol. 48, No. 6, 01.07.2019, p. 780-786.

Research output: Contribution to journalArticle

Barkin, JA, Westermann, A, Hoos, W, Moravek, C, Matrisian, L, Wang, H, Shemanski, L, Barkin, JS & Rahib, L 2019, 'Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients', Pancreas, vol. 48, no. 6, pp. 780-786. https://doi.org/10.1097/MPA.0000000000001330
Barkin, Jodie A. ; Westermann, Amy ; Hoos, William ; Moravek, Cassadie ; Matrisian, Lynn ; Wang, Hongwei ; Shemanski, Lynn ; Barkin, Jamie S ; Rahib, Lola. / Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients. In: Pancreas. 2019 ; Vol. 48, No. 6. pp. 780-786.
@article{d56e45c5cff642098c9ca38606f41ba3,
title = "Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients",
abstract = "Pancreatic cancer (PC) and its treatments can result in pancreatic exocrine insufficiency that requires pancreatic enzyme replacement therapy (PERT). Appropriate PERT usage is during meals and snacks. The aim was to determine the frequency of appropriate use of PERT and its impact on symptom alleviation in PC through a patient-reported outcomes online platform. Methods Users in the Pancreatic Cancer Action Network's Patient Registry were prompted to answer a standalone questionnaire about their experience with PERT. Results Two hundred sixty-two users completed the PERT questionnaire (January 2016-January 2018). Patients who reported taking PERT with meals had higher alleviation of symptoms compared with those taking PERT prior to or after meals. Specifically, {"}feeling of indigestion,{"} {"}light-colored or orange stools,{"} and {"}visible food particles in stool{"} were significantly decreased. Patients taking PERT with meals reported weight gain and less weight loss. Conclusions Of the 89{\%} of PC patients prescribed PERT, 65{\%} were prescribed PERT appropriately with all meals and snacks. Overall compliance with PERT administration guidelines was low (50{\%} [105/208]). Improvement in symptoms significantly correlated with appropriate use of PERT. Increase in PC patient and provider education about appropriate PERT usage and administration is warranted.",
keywords = "pancreatic cancer, pancreatic enzyme replacement therapy, pancreatic enzymes, pancreatic exocrine insufficiency, symptom alleviation, weight loss",
author = "Barkin, {Jodie A.} and Amy Westermann and William Hoos and Cassadie Moravek and Lynn Matrisian and Hongwei Wang and Lynn Shemanski and Barkin, {Jamie S} and Lola Rahib",
year = "2019",
month = "7",
day = "1",
doi = "10.1097/MPA.0000000000001330",
language = "English (US)",
volume = "48",
pages = "780--786",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients

AU - Barkin, Jodie A.

AU - Westermann, Amy

AU - Hoos, William

AU - Moravek, Cassadie

AU - Matrisian, Lynn

AU - Wang, Hongwei

AU - Shemanski, Lynn

AU - Barkin, Jamie S

AU - Rahib, Lola

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Pancreatic cancer (PC) and its treatments can result in pancreatic exocrine insufficiency that requires pancreatic enzyme replacement therapy (PERT). Appropriate PERT usage is during meals and snacks. The aim was to determine the frequency of appropriate use of PERT and its impact on symptom alleviation in PC through a patient-reported outcomes online platform. Methods Users in the Pancreatic Cancer Action Network's Patient Registry were prompted to answer a standalone questionnaire about their experience with PERT. Results Two hundred sixty-two users completed the PERT questionnaire (January 2016-January 2018). Patients who reported taking PERT with meals had higher alleviation of symptoms compared with those taking PERT prior to or after meals. Specifically, "feeling of indigestion," "light-colored or orange stools," and "visible food particles in stool" were significantly decreased. Patients taking PERT with meals reported weight gain and less weight loss. Conclusions Of the 89% of PC patients prescribed PERT, 65% were prescribed PERT appropriately with all meals and snacks. Overall compliance with PERT administration guidelines was low (50% [105/208]). Improvement in symptoms significantly correlated with appropriate use of PERT. Increase in PC patient and provider education about appropriate PERT usage and administration is warranted.

AB - Pancreatic cancer (PC) and its treatments can result in pancreatic exocrine insufficiency that requires pancreatic enzyme replacement therapy (PERT). Appropriate PERT usage is during meals and snacks. The aim was to determine the frequency of appropriate use of PERT and its impact on symptom alleviation in PC through a patient-reported outcomes online platform. Methods Users in the Pancreatic Cancer Action Network's Patient Registry were prompted to answer a standalone questionnaire about their experience with PERT. Results Two hundred sixty-two users completed the PERT questionnaire (January 2016-January 2018). Patients who reported taking PERT with meals had higher alleviation of symptoms compared with those taking PERT prior to or after meals. Specifically, "feeling of indigestion," "light-colored or orange stools," and "visible food particles in stool" were significantly decreased. Patients taking PERT with meals reported weight gain and less weight loss. Conclusions Of the 89% of PC patients prescribed PERT, 65% were prescribed PERT appropriately with all meals and snacks. Overall compliance with PERT administration guidelines was low (50% [105/208]). Improvement in symptoms significantly correlated with appropriate use of PERT. Increase in PC patient and provider education about appropriate PERT usage and administration is warranted.

KW - pancreatic cancer

KW - pancreatic enzyme replacement therapy

KW - pancreatic enzymes

KW - pancreatic exocrine insufficiency

KW - symptom alleviation

KW - weight loss

UR - http://www.scopus.com/inward/record.url?scp=85067604156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067604156&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000001330

DO - 10.1097/MPA.0000000000001330

M3 - Article

C2 - 31210656

AN - SCOPUS:85067604156

VL - 48

SP - 780

EP - 786

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 6

ER -